INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 99 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,506,000 | +0.9% | 161,600 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,493,000 | +6.0% | 161,600 | 0.0% | 0.00% | +33.3% |
Q1 2016 | $1,408,000 | +29.7% | 161,600 | 0.0% | 0.00% | +50.0% |
Q4 2015 | $1,086,000 | +16.3% | 161,600 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $934,000 | -29.2% | 161,600 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $1,319,000 | -78.5% | 161,600 | -78.5% | 0.00% | -75.0% |
Q1 2015 | $6,134,000 | -10.8% | 751,813 | +0.4% | 0.01% | -14.3% |
Q4 2014 | $6,876,000 | -6.6% | 749,039 | +0.2% | 0.01% | -12.5% |
Q3 2014 | $7,362,000 | – | 747,422 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |